When Donald Trump was elected president in November 2016, repealing the Affordable Care Act (ACA) suddenly became an attainable goal for Republicans in Congress, though it ultimately did not come to fruition as they had hoped. Here, we look back at the legislative twists and turns of ACA repeal efforts in 2017.
When Donald Trump was elected president in November 2016, repealing the Affordable Care Act (ACA) suddenly became an attainable goal for Republicans in Congress. However, with a slim 52-48 majority in the Senate, competing motivations of GOP lawmakers, and the complex rules of budget reconciliation to contend with, the path to that goal was more arduous than anticipated and ultimately did not result in legislation being passed before the September 30 budget deadline.
From the release of the House’s first healthcare bill to the eventual defeat of the Senate’s revised bill to the failure of a last-minute repeal plan, it can be hard to keep track of the different versions of ACA repeal-and-replace legislation winding their way through Congress.
This infographic was first published after several repeal bills were rejected by the Senate in late July, and it seemed that Congress would move on from healthcare to other legislative priorities. It has been updated to include the Graham-Cassidy bill, which was pulled on September 26 before a Senate vote could be held. The bill had represented Republicans’ last chance at passing repeal before the window to use 2017 budget reconciliation rules expired.
For a look back at the legislative twists and turns of ACA repeal efforts in 2017, see the infographic below.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More